Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug...
Hence then, the article about medtronic expand uro u s clinical trial meets safety and effectiveness primary endpoints for hugo robotic assisted surgery system was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system )
Also on site :
- Germany plans to take 40% in Leopard tank maker KNDS, joining France as stakeholder
- As public sentiment sours, Indonesia awaits MSCI verdict which risks $13 billion in capital outflows
- Lucid Motors’ new CEO cuts 18% of staff to ‘simplify the company’